ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director and 10% owner Jonathan Silverstein bought $9.5M of Arcutis Biotherapeutics, Inc.
Bought$9,501,096
$17.00Price
558,888Shares
What ARQT did for a copier
Prices for ARQT after this filing aren't in yet.
Jonathan Silverstein's record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Feb 3. Filed Tue, Feb 4, 12:27 PM ET, during the session. Not investment advice.